Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

312 evidences · page 6 / 13

3,6 %Bangladesh accounted for 3.6% of the global total of people with TB in 2019.

Nigeriatuberculoseobservé 2019publié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 18 observations

3,2 %One (3.2%) of the 32 patients with diabetes mellitus (DM) were diagnosed with tuberculosis (TB).

Nigeriadiabète (non précisé) · tuberculoseobservé 2017publié 2022West African journal of medicinePubMeddocument de 14 observations

35,5 yearsThe mean age of tuberculosis patients in Jos-North and Mangu Local Government Areas of Plateau State, Nigeria, was 35.5 years with a standard deviation of 15.5 years between 2001 and 2015.

Nigeriatuberculoseobservé 2001–2015publié 2020BMC public healthPubMeddocument de 7 observations

0,34 adjusted_hazard_ratioPatients with MDR-TB had a significantly lower risk of death compared to those with pre-XDR-TB, with an adjusted hazard ratio of 0.34.

Nigeriapre-XDR-TB · tuberculoseobservé 2012-2021publié 2023Nigerian journal of clinical practicePubMeddocument de 7 observations

42,3 %The tuberculosis-HIV co-morbidity rate was 42.3% among 241 TB patients in a semi-urban tuberculosis center in Southeast Nigeria between September 2014 and August 2017.

Nigeriatuberculose · VIH/sidaobservé September 2014 and August 2017publié 2021West African journal of medicinePubMeddocument de 10 observations

All eleven newly detected tuberculosis patients were placed on anti-TB treatment.

Nigeriatuberculosepublié 2020Advances in respiratory medicinePubMeddocument de 7 observations

41,4 %Ninety-two patients (41.4%) were successfully treated and discharged home.

Nigeriatuberculoseobservé 2013 to 2015publié 2022African health sciencesPubMeddocument de 4 observations

0,37 aORBeing HIV positive was associated with a reduced likelihood of successful tuberculosis treatment outcome (adjusted odds ratio = 0.37).

Nigeriatuberculose · VIH/sidaobservé 2010-2016publié 2021PloS onePubMeddocument de 3 observations

30 %Only 30% of the 3.5 million five-year target for children treated for TB was met.

Nigeriatuberculosepublié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 18 observations

0,8 %The overall prevalence of tuberculosis among diabetes mellitus patients in the study was 0.8% (800 per 100,000).

Nigeriadiabète (non précisé) · tuberculosepublié 2020Advances in respiratory medicinePubMeddocument de 7 observations

26,3 %The cure rate of tuberculosis (TB) patients was 26.3%.

Nigeriatuberculosepublié 2020PloS onePubMeddocument de 4 observations

88,8 %Of the 24,802 presumptive tuberculosis cases, 88.8% were tested for tuberculosis.

Nigeriatuberculosepublié 2024Global health, science and practicePubMeddocument de 15 observations

16,7 %Six deaths (16.7%) were recorded in the course of the study.

Nigeriatuberculose · VIH/sidapublié 2026Annals of African medicinePubMeddocument de 11 observations

17 %Variations between reported and actual treatment outcomes for tuberculosis patients in Lagos private DOTS facilities included 17% misclassification among those reported as cured.

Nigeriatuberculoseobservé 2016publié 2022Frontiers in public healthPubMeddocument de 11 observations

33,33 %Among mycobacterial isolates from suspected TB patients in Benue State, Nigeria, 33.33% were identified as MTBC.

Nigeriatuberculoseobservé July 2016 to February 2018publié 2020Ethiopian journal of health sciencesPubMeddocument de 10 observations

66,6 %At 6 months after commencement of TB treatment, 1842 (66.6%) of 2764 patients remained in care at an HIV clinic in Nigeria.

Nigeriatuberculosepublié 2022Journal of the International Association of Providers of AIDS CarePubMeddocument de 7 observations

66,34 %Among 2,169 presumptive pulmonary TB patients in Southwestern Nigeria, 66.34% (1439/2169) were GeneXpert positive.

Nigeriatuberculosepublié 2024The Pan African medical journalPubMeddocument de 10 observations

39,9 %Among 2652 TB/HIV co-infected patients in seven PEPFAR-supported states in Nigeria, TB treatment success was observed in 39.9% (cured) and 44.7% (completed).

Nigeriatuberculose · VIH/sidapublié 2024The Pan African medical journalPubMeddocument de 5 observations

69,8 %Majority of the respondents (423, 69.8%) had good tuberculosis preventive practices.

Nigeriatuberculosepublié 2023African health sciencesPubMeddocument de 7 observations

1,486 AORParticipants who commenced isoniazid before TB diagnosis had a higher likelihood of favorable TB treatment outcome compared to those who did not commence isoniazid before TB diagnosis (adjusted odds ratio = 1.486, 95% confidence interval = 1.047–2.109).

Nigeriatuberculosepublié 2024The Pan African medical journalPubMeddocument de 5 observations

25 %Tuberculosis recorded a coefficient of determination (R²) of 0.25, indicating that 25% of the variance in confirmed tuberculosis diagnoses was explained by the studied risk factors.

Nigeriatuberculoseobservé 2021publié 2026BMC infectious diseasesPubMeddocument de 17 observations

10,5 %A proportion of females (10.5%) were less likely to show an understanding of the complementary association of HIV and TB than males (14.8%).

Nigeriatuberculose · VIH/sidapublié 2024BMC public healthPubMeddocument de 4 observations

208 000 deathsThere were an additional 208,000 TB deaths among people living with HIV in 2019.

Nigeriatuberculoseobservé 2019publié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 18 observations

11,5 %At 6 months, 11.5% of TB patients had positive IgG levels.

Nigeriatuberculosepublié 2022Frontiers in cellular and infection microbiologyPubMeddocument de 15 observations

88 %Adults accounted for 88% of people with TB in 2019.

Nigeriatuberculoseobservé 2019publié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 18 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.